AGF Investments Inc’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,568
Closed -$31K 746
2021
Q4
$31K Buy
1,568
+26
+2% +$489 ﹤0.01% 668
2021
Q3
$28K Hold
1,542
﹤0.01% 678
2021
Q2
$42K Buy
1,542
+34
+2% +$951 ﹤0.01% 683
2021
Q1
$45K Sell
1,508
-6
-0.4% -$205 ﹤0.01% 699
2020
Q4
$44K Buy
1,514
+34
+2% +$918 ﹤0.01% 676
2020
Q3
$36K Buy
1,480
+33
+2% +$712 ﹤0.01% 693
2020
Q2
$26K Sell
1,447
-132
-8% -$1.74K ﹤0.01% 692
2020
Q1
$13K Buy
1,579
+54
+4% +$617 ﹤0.01% 690
2019
Q4
$20K Buy
1,525
+98
+7% +$1.19K ﹤0.01% 337
2019
Q3
$17K Buy
1,427
+303
+27% +$5.61K ﹤0.01% 335
2019
Q2
$27K Buy
+1,124
New +$32.4K ﹤0.01% 324

Other funds holding CVET

AGF Investments Inc's CVET Position: Q1 2022 in Review

AGF Investments Inc sold out of Covetrus, Inc. Common Stock (CVET) in Q1 2022, closing a stake of 1,568 shares — an estimated $31K sold.

AGF Investments Inc first reported a position in CVET in Q2 2019 and held it in 11 quarters. The position peaked at $45K in Q1 2021. 257 funds tracked by Wall St. Rank hold CVET as of Q1 2022.

  • AGF Investments Inc reported no remaining Covetrus, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 1,568 Covetrus, Inc. Common Stock shares in Q1 2022, an estimated $31K.
  • AGF Investments Inc first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 11 quarters.
  • AGF Investments Inc's Covetrus, Inc. Common Stock position peaked at $45K in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.